Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats-Reference-Cited by-同舟云学术

Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats

Published:2000-10 Issue:4 Volume:42 Page:337-343
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Fundarò Anna,Cavalli Roberta,Bargoni Alessandro,Vighetto Daniela,Zara Gian Paolo,Gasco Maria Rosa

Publisher

Elsevier BV

Subject

Pharmacology

Reference21 articles.

1. An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation;Gokhale;Br J Cancer,1996

2. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles;Verdun;Cancer Chemother Pharmacol,1990

3. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release;Yoo;Pharm Res,1999

4. Amphipatic polyethylene glycols effectively prolong the circulation time of liposomes;Kilbanov;FEBS Lett,1990

5. Long-circulating microparticulate drug carriers;Stolnik;Adv Drug Del Rev,1995

Cited by 278 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melphalan delivery and co-delivery nanoformulations for cancer therapy: A comprehensive review;European Journal of Medicinal Chemistry Reports;2024-12

2. AN UPDATED REVIEW OF STEALTH LIPOSOMES AND ITS ABILITY TO EVADE THE IMMUNE SYSTEM: A NEW FRONTIER IN CANCER CHEMOTHERAPY;International Journal of Applied Pharmaceutics;2024-05-07

3. Curcumin in treatment of hematological cancers: Promises and challenges;Journal of Traditional and Complementary Medicine;2024-03

4. Construction and evaluation of a nanosystem that combines acidification promoted chemodynamic therapy and intracellular drug release monitoring;Journal of Biotechnology;2024-03

5. A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin Nanosimilars;ACS Nano;2024-02-15